CR

(redirected from Complete Response)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia.

CR

The two-character ISO 3166 country code for COSTA RICA.

CR

1. ISO 3166-1 alpha-2 code for the Republic of Costa Rica. This is the code used in international transactions to and from Costa Rican bank accounts.

2. ISO 3166-2 geocode for Costa Rica. This is used as an international standard for shipping to Costa Rica. Each Costa Rican province has its own code with the prefix "CR." For example, the code for the Province of Limon is ISO 3166-2:CR-L.
References in periodicals archive ?
How can applicants reduce the risk that the FDA will issue a Complete Response letter?
Because the most recent Complete Response Letter did not contain any specific requirement to conduct any additional clinical work or other specific guidance to address the issue raised by the FDA, Somaxon believes that a meeting with the FDA will be necessary to discuss the basis for the FDA's decision and to seek such specific guidance.
In its Complete Response letter, the FDA states that it cannot approve the NDA in its current form and specifies additional actions and information required by the Agency for approval of the Gencaro NDA.
AMAG Pharmaceuticals, a United States-based pharmaceutical company, has received a complete response letter for its application seeking approval for a single-dose vial of Makena (hydroxyprogesterone caproate injection) from the United States Food and Drug Administration, it was reported yesterday.
CHICAGO -- Biogen Idec (NASDAQ: BIIB) announced today that data presented at the 43rd American Society of Clinical Oncology (ASCO) annual meeting showed that adding Zevalin([R]) (Ibritumomab tiuxetan) radioimmunotherapy to a short course first-line treatment followed by rituximab weekly for four weeks doubled the rate of complete response in patients with follicular lymphoma, from 44 percent with a standard treatment regimen to 88 percent.
M2 EQUITYBITES-December 30, 2013-Genzyme announces receipt of Complete Response Letter from US FDA on supplemental Biologics License Application for Lemtrada
M2 PHARMA-January 22, 2013-Impax Pharmaceuticals gets FDA's complete response letter for RYTARY's NDA(C)2013 M2 COMMUNICATIONS
When added to the FCR regimen, lumiliximab demonstrated a 52 percent complete response (CR) rate in patients who have CLL that was progressing after prior therapy.
M2 EQUITYBITES-September 9, 2013-Endo Pharmaceuticals submits complete response to new drug application for AVEED(C)2013 M2 COMMUNICATIONS http://www.
M2 PHARMA-September 10, 2012-Janssen Research & Development LLC submits complete response for XARELTO(C)2012 M2 COMMUNICATIONS
Full browser ?